MedPacto Market Capitalization vs. Gross Profit
| 235980 Stock | KRW 5,040 260.00 4.91% |
For MedPacto profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MedPacto to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MedPacto utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MedPacto's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MedPacto over time as well as its relative position and ranking within its peers.
MedPacto |
MedPacto Gross Profit vs. Market Capitalization Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining MedPacto's current stock value. Our valuation model uses many indicators to compare MedPacto value to that of its competitors to determine the firm's financial worth. MedPacto is number one stock in market capitalization category among its peers. It also is number one stock in gross profit category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value MedPacto by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for MedPacto's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.MedPacto Market Capitalization vs. Competition
MedPacto is number one stock in market capitalization category among its peers. Market capitalization of Biotechnology industry is presently estimated at about 990.47 Billion. MedPacto totals roughly 440.59 Billion in market capitalization claiming about 44% of stocks in Biotechnology industry.
MedPacto Gross Profit vs. Market Capitalization
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
MedPacto |
| = | 440.59 B |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
MedPacto |
| = | (1.66 M) |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
MedPacto Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in MedPacto, profitability is also one of the essential criteria for including it into their portfolios because, without profit, MedPacto will eventually generate negative long term returns. The profitability progress is the general direction of MedPacto's change in net profit over the period of time. It can combine multiple indicators of MedPacto, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
MedPacto, Inc., a drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea. The company is developing ME-1601mAb that targets BSP1 for cancers MS-1601A that targets TRG1 for cancers and autoimmune diseases and vactosertib for solid tumors. MedPacto is traded on Korean Securities Dealers Automated Quotations in South Korea.
MedPacto Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on MedPacto. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MedPacto position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MedPacto's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in MedPacto without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Use Investing Themes to Complement your MedPacto position
In addition to having MedPacto in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Services Thematic Idea Now
Services
Companies involved in delivering services to business or consumers across different industries and sectors. The Services theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Services Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in MedPacto Stock
To fully project MedPacto's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of MedPacto at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include MedPacto's income statement, its balance sheet, and the statement of cash flows.